HPV vax successfully treats precancerous lesions

Millions of women who carry the human papillomavirus suffer from precancerous lesions. But a small study indicates that an HPV vaccine may either improve their condition or cure it altogether, preventing malignancies in the vulva.

In a small trial, researchers tested the vaccine on 20 women who suffered from these lesions. And four out of five patients reported that the lesions had either been reduced or eliminated. Half had no sign of the lesions two years after treatment.

"This shows that it is possible to vaccinate against chronic disease, as well as treat HPV-induced premalignance," said study co-author Sjoerd H. van der Burg. If this new approach is proven in larger trials, women will have a shot at replacing surgery or laser and freezing treatments with the vaccine.

- read the story from U.S. News & World Report 

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.